The role of Interleukin-21 (IL-21) in allergic disorders: Biological insights and regulatory mechanisms

  • Mohamed J. Saadh
  • , Mohammed A. Alfattah
  • , Ahmed H. Ismail
  • , Bashar Abdullah Saeed
  • , Huda hayder abbas
  • , Nabila F. Elashmawy
  • , Ghassan A. hashim
  • , Khatib Sayeed Ismail
  • , Mabrouk A. Abo-Zaid
  • , Hisham Ali Waggiallah

Research output: Contribution to journalReview articlepeer-review

5 Scopus citations

Abstract

In recent decades, allergic diseases subsequent from an IgE-mediated response to specific allergens have become a progressively public chronic disease worldwide. They have shaped an important medical and socio-economic burden. A significant proportion of allergic disorders are branded via a form 2 immune response relating Th2 cells, type 2 natural lymphoid cells, mast cells and eosinophils. Interleukin-21 (IL-21) is a participant of the type-I cytokine family manufactured through numerous subsets of stimulated CD4+ T cells and uses controlling properties on a diversity of immune cells. Increasingly, experimental sign suggests a character for IL-21 in the pathogenesis of numerous allergic disorders. The purpose of this review is to discuss the biological properties of IL-21 and to summaries current developments in its role in the regulation of allergic disorders.

Original languageEnglish
Article number111825
JournalInternational Immunopharmacology
Volume134
DOIs
StatePublished - 15 Jun 2024

Keywords

  • Allergic diseases
  • Asthma
  • Cytokine
  • IL-21
  • Interleukin

Fingerprint

Dive into the research topics of 'The role of Interleukin-21 (IL-21) in allergic disorders: Biological insights and regulatory mechanisms'. Together they form a unique fingerprint.

Cite this